SE461892B - Oljeloeslig komposition av vitamin b -butyrat - Google Patents
Oljeloeslig komposition av vitamin b -butyratInfo
- Publication number
- SE461892B SE461892B SE8301565A SE8301565A SE461892B SE 461892 B SE461892 B SE 461892B SE 8301565 A SE8301565 A SE 8301565A SE 8301565 A SE8301565 A SE 8301565A SE 461892 B SE461892 B SE 461892B
- Authority
- SE
- Sweden
- Prior art keywords
- oil
- vitamin
- butyrate
- fatty acid
- fifi
- Prior art date
Links
- 229940088594 vitamin Drugs 0.000 title claims description 33
- 229930003231 vitamin Natural products 0.000 title claims description 33
- 235000013343 vitamin Nutrition 0.000 title claims description 33
- 239000011782 vitamin Substances 0.000 title claims description 33
- 239000000203 mixture Substances 0.000 title claims description 29
- 150000003722 vitamin derivatives Chemical class 0.000 title claims description 29
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 title description 9
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 title description 8
- -1 glycerol diester Chemical class 0.000 claims description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- 239000000194 fatty acid Substances 0.000 claims description 17
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 16
- 229930195729 fatty acid Natural products 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims 2
- 235000005911 diet Nutrition 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 13
- 239000008158 vegetable oil Substances 0.000 description 13
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 11
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 11
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 11
- 239000005642 Oleic acid Substances 0.000 description 11
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 11
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 5
- 229960002446 octanoic acid Drugs 0.000 description 5
- 239000005639 Lauric acid Substances 0.000 description 4
- 235000019484 Rapeseed oil Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000010497 wheat germ oil Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 241001446467 Mama Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 150000005691 triesters Chemical class 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57091466A JPS58208215A (ja) | 1982-05-31 | 1982-05-31 | 脂溶性ビタミン配合油溶組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8301565D0 SE8301565D0 (sv) | 1983-03-22 |
| SE8301565L SE8301565L (sv) | 1983-12-01 |
| SE461892B true SE461892B (sv) | 1990-04-09 |
Family
ID=14027151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8301565A SE461892B (sv) | 1982-05-31 | 1983-03-22 | Oljeloeslig komposition av vitamin b -butyrat |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS58208215A (enExample) |
| CH (1) | CH656531A5 (enExample) |
| DE (1) | DE3311008C2 (enExample) |
| FR (1) | FR2527440B1 (enExample) |
| GB (1) | GB2120935B (enExample) |
| SE (1) | SE461892B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| JPS63130535A (ja) * | 1986-11-19 | 1988-06-02 | Nisshin Kagaku Kk | 経口投与用抗ヒスタミン剤 |
| US7081445B2 (en) | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms |
| GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
| KR20040004416A (ko) | 1997-01-30 | 2004-01-13 | 노파르티스 아게 | 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR8014M (enExample) * | 1968-01-09 | 1970-07-27 | ||
| US3962436A (en) * | 1969-06-03 | 1976-06-08 | Sumitomo Chemical Company, Limited | Pharmaceutical compositions having controlled rate of gastro-intestinal absorption |
| NL7012460A (enExample) * | 1970-08-22 | 1972-02-24 | ||
| US3932634A (en) * | 1973-06-28 | 1976-01-13 | Pfizer Inc. | High potency vitamin water dispersible formulations |
-
1982
- 1982-05-31 JP JP57091466A patent/JPS58208215A/ja active Granted
-
1983
- 1983-03-18 GB GB08307543A patent/GB2120935B/en not_active Expired
- 1983-03-22 SE SE8301565A patent/SE461892B/sv not_active IP Right Cessation
- 1983-03-25 DE DE3311008A patent/DE3311008C2/de not_active Expired
- 1983-03-25 CH CH1664/83A patent/CH656531A5/de not_active IP Right Cessation
- 1983-03-30 FR FR8305239A patent/FR2527440B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE8301565D0 (sv) | 1983-03-22 |
| GB2120935A (en) | 1983-12-14 |
| DE3311008A1 (de) | 1983-12-01 |
| CH656531A5 (de) | 1986-07-15 |
| FR2527440A1 (fr) | 1983-12-02 |
| GB8307543D0 (en) | 1983-04-27 |
| FR2527440B1 (fr) | 1987-05-15 |
| DE3311008C2 (de) | 1986-04-10 |
| GB2120935B (en) | 1985-10-23 |
| SE8301565L (sv) | 1983-12-01 |
| JPH044299B2 (enExample) | 1992-01-27 |
| JPS58208215A (ja) | 1983-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thompson | A biochemical approach to the problem of multiple sclerosis | |
| Glass et al. | The occurrence and distribution of furan fatty acids in spawning male freshwater fish | |
| Rosenman et al. | Behavior patterns, blood lipids, and coronary heart disease | |
| JP2677554B2 (ja) | 乾燥した微粒子のさらさらした安定なトコフエロール | |
| Gutfinger et al. | Studies of unsaponifiables in several vegetable oils | |
| DE60018372T2 (de) | Oralzusammensetzung als mikroemulsion von silybin | |
| DE69201216T2 (de) | Öllösliche Antioxydationsmischung. | |
| DE69723671T2 (de) | Cyclosüporin formulierung | |
| KR840005339A (ko) | 지용성물질을 함유한 수용액의 제조방법 | |
| Evarts et al. | Ratios of polyunsaturated fatty acids to α-tocopherol in tissues of rats fed corn or soybean oils | |
| GB1386260A (en) | Shortening for highly aerated creamy frostings | |
| EP0196085B1 (en) | Composition containing ubidecarenone with promoted absorption | |
| SE461892B (sv) | Oljeloeslig komposition av vitamin b -butyrat | |
| SI9720010B (sl) | Ciklosporin vsebujoči mehki kapsulni pripravki | |
| Kritchevsky et al. | Cholesterol vehicle in experimental atherosclerosis: X. Influence of specific saturated fatty acids | |
| Sotheeswaran et al. | Lipids from the seeds of seven Fijian plant species | |
| Butterworth et al. | A quantitative comparison of the sympathomimetic amine content of the left and right adrenal glands of the cat | |
| Kritchevsky et al. | Solubility of Cholesterol in Various Fats and Oils. | |
| US2686751A (en) | Vitamin a stabilization | |
| Saddler et al. | Fatty acid alterations during migration and early sea water growth of chum salmon (Oncorhynchus keta) | |
| US2895878A (en) | Compositions containing stabilized vitamin a materials | |
| US3458637A (en) | Compositions stabilized with tocopheramine antioxidants | |
| Yuan et al. | Comparative analysis of essential bioactive components of oils originating from three Chinese Loess Plateau wild crops | |
| Tokuda et al. | Effects of excess doses of α-tocopherol on lipid in serum and muscle of rainbow trout | |
| Svoboda et al. | Reduction of blood and liver cholesterol in the rat by straight and branched chain alkyl amines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8301565-1 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |